spacer
spacer

PDBsum entry 5njh

Go to PDB code: 
Top Page protein ligands metals Protein-protein interface(s) links
Structural protein PDB id
5njh
Contents
Protein chains
435 a.a.
413 a.a.
121 a.a.
339 a.a.
Ligands
GTP ×2
GDP ×2
8Z8
ACP
Metals
_MG ×5
Waters ×361

References listed in PDB file
Key reference
Title Triazolopyrimidines are microtubule-Stabilizing agents that bind the vinca inhibitor site of tubulin.
Authors G.Sáez-Calvo, A.Sharma, F.A.Balaguer, I.Barasoain, J.Rodríguez-Salarichs, N.Olieric, H.Muñoz-Hernández, M...Berbís, S.Wendeborn, M.A.Peñalva, R.Matesanz, ..Canales, A.E.Prota, J.Jímenez-Barbero, J.M.Andreu, C.Lamberth, M.O.Steinmetz, J.F.Díaz.
Ref. Cell Chem Biol, 2017, 24, 737. [DOI no: 10.1016/j.chembiol.2017.05.016]
PubMed id 28579361
Abstract
Microtubule-targeting agents (MTAs) are some of the clinically most successful anti-cancer drugs. Unfortunately, instances of multidrug resistances to MTA have been reported, which highlights the need for developing MTAs with different mechanistic properties. One less explored class of MTAs are [1,2,4]triazolo[1,5-a]pyrimidines (TPs). These cytotoxic compounds are microtubule-stabilizing agents that inexplicably bind to vinblastine binding site on tubulin, which is typically targeted by microtubule-destabilizing agents. Here we used cellular, biochemical, and structural biology approaches to address this apparent discrepancy. Our results establish TPs as vinca-site microtubule-stabilizing agents that promote longitudinal tubulin contacts in microtubules, in contrast to classical microtubule-stabilizing agents that primarily promote lateral contacts. Additionally we observe that TPs studied here are not affected by p-glycoprotein overexpression, and suggest that TPs are promising ligands against multidrug-resistant cancer cells.
PROCHECK
Go to PROCHECK summary
 Headers

 

spacer

spacer